> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Drug Labeling Info Collection
- URL: https://www.fdaweb.com/comments-sought-on-drug-labeling-info-collection/
- Published: 2018-07-20T12:00:00.000Z
- Updated: 2026-09-15T00:20:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141925

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products” (OMB Control Number 0910–0572). FDA’s regulations require that the labeling of new and recently approved products contain highlights of prescribing information, a table of contents for prescribing information, reordering of certain sections, minor content changes, and minimum graphical requirements. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-07-20/pdf/2018-15512.pdf?ref=fdaweb.com).